CJZ3, a lomerizine derivative, modulates P-glycoprotein function in rat brain microvessel endothelial cells.
Bian-Sheng Ji, Ling He, Xiao-Qu Li, Guo-Qing Liu
Index: Acta Pharmacol. Sin. 27(4) , 414-8, (2006)
Full Text: HTML
Abstract
To investigate the modulatory effect of CJZ3, a lomerizine derivative, on P-glycoprotein (P-gp) function in rat brain microvessel endothelial cells (RBMEC).RBMEC were isolated and cultured in Dulbecco modified Eagle medium/F12 (1:1) medium, and the amount of intracellular rhodamine 123 (Rh123) was determined using a fluorescence spectrophotometer to evaluate the modulatory effect of CJZ3 on P-gp function.The accumulation of Rh123 was potentiated in a concentration-dependent manner after incubation with CJZ3 for RBMEC, but not for human umbilical vein endothelial cells (HUVEC). CJZ3 caused the accumulation of intracellular Rh123 in a time-dependent manner and significantly decreased the efflux of Rh123 from the cells. The inhibitory effect of CJZ3 on P-gp function was reversible and remained for 120 min after CJZ3 (2.5 micromol/L) was removed from the medium.CJZ3 has a potent in vitro effect on the inhibition of P-gp function.
Related Compounds
Related Articles:
2015-06-03
[Sci. Transl. Med. 7 , 290ra89, (2015)]
2011-12-01
[Mol. Cell Biochem. 358(1-2) , 1-11, (2011)]
2008-09-01
[J. Pharmacol. Sci. 108(1) , 89-94, (2008)]
2006-03-01
[Curr. Eye Res. 31(3) , 273-83, (2006)]
Increase in doxorubicin cytotoxicity by inhibition of P-glycoprotein activity with lomerizine.
2001-05-01
[Biol. Pharm. Bull. 24(5) , 555-7, (2001)]